- Home
- LAES vs AMLX Comparison
LAES vs AMLX Comparison
Compare LAES & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- AMLX
- Stock Information
- Founded
- LAES 2022
- AMLX 2014
- Country
- LAES Switzerland
- AMLX United States
- Employees
- LAES N/A
- AMLX N/A
- Industry
- LAES Semiconductors
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- AMLX Health Care
- Exchange
- LAES Nasdaq
- AMLX Nasdaq
- Market Cap
- LAES 315.9M
- AMLX 330.5M
- IPO Year
- LAES N/A
- AMLX 2022
- Fundamental
- Price
- LAES $2.76
- AMLX $3.70
- Analyst Decision
- LAES Strong Buy
- AMLX Buy
- Analyst Count
- LAES 1
- AMLX 4
- Target Price
- LAES $6.00
- AMLX $7.50
- AVG Volume (30 Days)
- LAES 10.1M
- AMLX 799.8K
- Earning Date
- LAES 04-15-2025
- AMLX 03-04-2025
- Dividend Yield
- LAES N/A
- AMLX N/A
- EPS Growth
- LAES N/A
- AMLX N/A
- EPS
- LAES N/A
- AMLX N/A
- Revenue
- LAES $10,981,000.00
- AMLX $87,371,000.00
- Revenue This Year
- LAES N/A
- AMLX N/A
- Revenue Next Year
- LAES N/A
- AMLX N/A
- P/E Ratio
- LAES N/A
- AMLX N/A
- Revenue Growth
- LAES N/A
- AMLX N/A
- 52 Week Low
- LAES $0.29
- AMLX $1.58
- 52 Week High
- LAES $11.00
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- LAES 44.51
- AMLX 43.25
- Support Level
- LAES $2.48
- AMLX $3.59
- Resistance Level
- LAES $2.79
- AMLX $3.93
- Average True Range (ATR)
- LAES 0.27
- AMLX 0.23
- MACD
- LAES -0.02
- AMLX -0.04
- Stochastic Oscillator
- LAES 17.61
- AMLX 18.83
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.